(Public Library of Science) A new international study reported in PLoS Medicine confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infants. However, the increased risk of failure could only be detected in women who began full HIV treatment within about a year after receiving sdNVP.
Further information:
Related posts:
- Smoking tied to lung cancer in women with HIV
- Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission
- A whole genome association study of mother-to-child transmission of HIV in Malawi
- Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients
- Effectiveness of Non-nucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Women Previously Exposed to a Single Intrapartum Dose of Nevirapine: A Multi-country, Prospective Cohort Study
Posted in